Additional information
Pale yellow Powder
2518153-95-0
ACI-020813
75.0-76.2°C
C11H12BrN3
266.14
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
N-propylamino-5-bromoquinoxaline
6-(2-imidazoline-2-ylidineamino)-1,2,3,4-tetrahydroquinoxalin-2,3-dione
2-Quinoxalinamine, 5-bromo-N-propyl





![N-DEMETHYL BOSUTINIB (25 mg) (4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(piperazin-1-yl)propoxy]quinoline-3-carbonitrile )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)